A late-stage trial showed that oral semaglutide significantly reduced blood sugar in 10- to 17-year-olds.

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with ...

Novo Nordisk A/S NVO reported positive topline results from its late-stage PIONEER TEENS trial, showing that oral semaglutide ...

Nearly half of patients with T2D have micronutrient deficiencies, with vitamin D deficiency affecting 60.45% of patients. Women with T2D show a higher prevalence of micronutrient deficiencies compared ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But with the growing popularity and effectiveness of medications like semaglutide ...

Younger patients benefit from stricter HbA1c goals, whereas elderly care focuses on symptom control. Glycemic targets should gradually adjust with aging to match changing health and life expectancy.

Please provide your email address to receive an email when new articles are posted on . Diabetes technologies have been evolving rapidly in recent years and now serve a wide range of patients. Usage ...

People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than ...

DEAR DR. ROACH: I have Type 2 diabetes. How often do I need to see my doctor? -- A.B. ANSWER: When a person is first diagnosed with Type 2 diabetes, a visit every three months is normally recommended.

When a doctor finds that a Type 2 diabetes patient is not controlling blood glucose levels with maximum dosing of metformin, and the patient's HbA1c is creeping towards 8% or higher, the challenge is ...

New research reveals that hidden hunger—deficiencies in key vitamins and minerals—is silently worsening Type 2 diabetes, affecting nearly half of patients worldwide. What does this mean for diabetes ...